Yiran Zhang

No ORCID on file · 4 papers in corpus · active 2022-2023

Study types

  • article 2
  • other 1
  • preprint 1

Condition tags

  • adenomyosis 4
article 2023
Establishment of an immortalized cell line derived from human adenomyosis ectopic lesions
Tissue & cell ·doi:10.1016/j.tice.2023.102284

Because adenomyosis (AM) ectopic primary cells are hard to come by, have a short lifespan, and the characteristics that alter over time, their utility in AM research is constrained. This study aimed to establish a line of immortalized human…

other 2022
Analysis of the Mechanism of GuizhiFuling Wan in Treating Adenomyosis Based on Network Pharmacology Combined with Molecular Docking and Experimental Verification
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2022/6350257

BACKGROUND: The effect of GuizhiFuling Wan (GFW) on adenomyosis (AM) is definite. This study aimed to explore the mechanism and key therapeutic targets of GFW in treating AM through network pharmacology combined with molecular docking and e…

article 2022
Mechanism Study of Cinnamomi Ramulus and Paris polyphylla Sm. Drug Pair in the Treatment of Adenomyosis by Network Pharmacology and Experimental Validation
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2022/2624434

OBJECTIVE: To explore the molecular mechanism of the Cinnamomi ramulus and Paris polyphylla Sm. (C-P) drug pair in the treatment of adenomyosis (AM) based on network pharmacology and animal experiments. METHODS: Via a network pharmacology …

preprint 2022
Trans-Cinnamaldehyde inhibition of cytoskeleton-induced invasion and migration by regulating the Rho/ROCK pathway in adenomyosis
·doi:10.22541/au.165519364.49734412/v1

Some of the key steps in adenomyosis (AM) are the migration and invasion of adenomyosis derived cells (AMDC); these processes require rearrangement of the cytoskeleton which Rho/ROCK signaling pathway is involved. The aim of the current stu…